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During forebrain development, LRP2 promotes
morphogen signaling as an auxiliary SHH receptor.
However, in the developing retina, LRP2 assumes
the opposing function, mediating endocytic clear-
ance of SHH and antagonizing morphogen action.
LRP2-mediated clearance prevents spread of SHH
activity from the central retina into the retinal margin
to protect quiescent progenitor cells in this niche
from mitogenic stimuli. Loss of LRP2 in mice in-
creases the sensitivity of the retinal margin for SHH,
causing expansion of the retinal progenitor cell
pool and hyperproliferation of this tissue. Our
findings document the ability of LRP2 to act, in a
context-dependent manner, as activator or inhibitor
of the SHH pathway. Our current findings uncovered
LRP2 activity as the molecular mechanism imposing
quiescence of the retinal margin in the mammalian
eye and suggest SHH-induced proliferation of the
retinal margin as cause of the large eye phenotype
observed in mouse models and patients with LRP2
defects.
INTRODUCTION
The low-density lipoprotein receptor-related protein (LRP) 2 is
amember of the LDL receptor gene family, a group of structurally
related cell surface receptors with important roles in embryonic
development (reviewed in Willnow et al., 2012). Earlier, we un-
covered the function of LRP2 as an auxiliary sonic hedgehog
(SHH) receptor required for mammalian forebrain formation
(Christ et al., 2012). At neurulation, LRP2 is expressed in neuro-
epithelial cells where it forms a complex with Patched (PTCH) 1
enabling SHH binding and signal reception in the rostral dien-
cephalon ventral midline (RDVM), the major forebrain organizer
region. Loss of LRP2 activity in mouse models results in the
inability of SHH to induce its target field in the ventral midline,
and, consequently, in midline formation defects and in holopro-
sencephaly (Christ et al., 2012). Holoprosencephalic features
are also seen in patients with Donnai-Barrow syndrome, an auto-36 Developmental Cell 35, 36–48, October 12, 2015 ª2015 Elsevier Isomal recessive disorder caused by LRP2 defects, documenting
the conservation of receptor function across species (Kantarci
et al., 2007; Rosenfeld et al., 2010).
To explore the significance of LRP2 for SHH activity in para-
digms other than forebrain patterning, we focused on retina
development, a process dependent on SHH signals (Neumann
and Nuesslein-Volhard, 2000; Wang et al., 2002). Our choice
was guided by large eye phenotypes seen in LRP2-deficient
humans (Pober et al., 2009) and mouse and zebrafish models
(Gajera et al., 2010; Veth et al., 2011). Yet, the mechanism of
LRP2 action during eye development and whether it functions
as SHH binding protein in this context remained unclear.
Here, we show that LRP2 is expressed in the peripheral margin
of themurine embryonic retina where it modulates SHH signaling
during retinal differentiation. However, in contrast to the situation
in the RDVM, in the retinal margin, LRP2 acts as an inhibitory
receptor that mediates cellular clearance of SHH, protecting
the retinal margin from detrimental mitogenic stimuli by this
morphogen. Absence of LRP2 in gene targeted mice results in
ectopic induction of SHH signaling and aberrant expansion of
the progenitor cell pool in the margin of the retina and in hyper-
plasia of peripheral retina tissue. These studies identified a clear-
ance function of LRP2 as a mechanism to control SHH signaling
in vivo and suggest excessive proliferation of the retinal margin
as cause of the large eye phenotype in LRP2-deficient patients
and mouse models.
RESULTS
Hereditary Buphthalmos in LRP2-Deficient Mice
We explored a role for LRP2 in the functional integrity of the
mammalian eye, a process disturbed by receptor deficiency in
humans and mice (Gajera et al., 2010; Pober et al., 2009; Storm
et al., 2014). We carried out our analyses using two different Lrp2
null alleles that disrupt LRP2 synthesis in mice. Analyses of em-
bryonic stages were performed in mice with targeted Lrp2 gene
disruption (Lrp2/) on a C57BL/6N background (Spoelgen
et al., 2005). For analysis of postnatal and adult stages,
Lrp2+/ animals were crossed with the ENU line 267 that
carries a premature stop codon in the sequence encoding the
extracellular domain of LRP2 (Lrp2267/+) (Zarbalis et al., 2004).
Compound heterozygous mice (Lrp2267/) exhibit a higher rate
of perinatal survival compared to Lrp2/ animals due to the
(FVB/NJ 3 C57BL/6J) background of line 267 (Gajera et al.,nc.
2010). For both alleles, LRP2-deficient animals (Lrp2/ or
Lrp2267/) were compared to their respective heterozygous or
wild-type littermates (jointly referred to as controls).
As reported previously, adult LRP2-deficient mice are charac-
terized by craniofacial malformations, including a shortened
snout and an open frontal fontanel, indicative ofmild holoprosen-
cephaly (Figures 1A–1D). However, adult Lrp2 mutant mice also
exhibit enlarged and exophthalmic eyes (buphthalmos) (Fig-
ure 1E), a defect not typically seen in holoprosencephalic syn-
drome. Enlarged globes are already apparent at postnatal day
(P) 10 (Figure 1F), with a 17% increase in axial length (Figure 1G).
Histological analyses (Figure 1H) confirmed enlargement of
Lrp2267/ adult (Figure 1H, b) and P10 eyes (Figure 1H, d)
compared to controls (Figures 1H, a and c). In both age groups,
mutant eyes showed thinning of the retina, but with normal strat-
ification (Figures 1H, e–h). In adults, the retina pathology was
advanced with glaucomatous changes that included cell loss
in the retinal ganglion cell layer (Figures S1A and S1B) and disor-
ganization of the nerve fiber layer in the area of the optic cup (Fig-
ure S1D). An additional morphological abnormality in adult and
P10 mutant eyes was the hyperplasia of the non-pigmented
epithelium of the ciliary body (CB) (Figures 1H, j and l). This tissue
is the main expression site of LRP2 in the postnatal mouse eye
(Figures 1H,m and o). In neonatal mutants, the eye size and anat-
omy of the retina was normal as shown by histology (Figure 1I)
and by immunodetection of photoreceptor cells and retinal
ganglion cells (Figure S1E). Still, an increase in CB mass was
apparent when compared to control eyes (Figures 1, e and f).
LRP2 Deficiency Causes Ectopic Induction of SHH
Signals in the Retinal Margin
Because CB hyperplasia was seen at early postnatal stages in
LRP2-deficient mice, we suspected a developmental defect as
cause of this phenotype. Thus, we characterized the expression
of LRP2 in wild-type embryos. Around E10.5, invagination of the
neuroepithelium in the optic pits forms the bi-layered optic cup
(Figure S2A). Expression of LRP2 on the apical surface of the
neuroepithelium at E10.5 is retained during optic cup invagina-
tion, resulting in receptor localization to the inner layer of the
optic cup epithelium (Figure S2B). Initially present throughout
the entire optic cup epithelium at E12.5, LRP2 expression be-
comes restricted to the peripheral margin as retina differentiation
proceeds. At E16.5, LRP2 is largely confined to the ciliary mar-
ginal zone (CMZ), which will give rise to the CB and iris in the
postnatal eye (Figures S2B and S2C). In the CMZ, LRP2 is posi-
tioned at the apical surface of non-pigmented ciliary epithelial
cells (Figures S2B–S2D).
In the mammalian eye, SHH is produced by retinal ganglion
cells. It provides inductive signals to retinal progenitor cells
(RPC), resulting in patterning of the neural retina in a central to pe-
ripheral direction (Neumann and Nuesslein-Volhard, 2000; Wang
et al., 2002). SHH activity is absent from the CMZ that, in turn,
receives signals fromWNT ligands and bonemorphogenetic pro-
teins (BMP) (Cho and Cepko, 2006; Zhao et al., 2002). To test
whether loss of LRP2 impairs SHH-dependent patterning of the
neural retina, we analyzed markers of retinal differentiation. The
histological appearance of the neural retina was comparable
in control and Lrp2/ eyes at E16.5 (Figures 2A and 2B). Also,
expression of Shh in the retinal ganglion cell layer (Figures 2C–Deve2F) and of the neurogenic marker Math5 (Figures 2G–2J) was
normal. Overall correct patterning of the mutant neural retina
was confirmed by immunodetection of Zic2 and Isl2, markers of
postmitotic retinal cell types (Figures 2K–2P). However, a subtle,
but consistent, alteration was seen for the retinal ganglion cell
marker Brn-3b. Expression of this marker was pronounced in
the central retina in both genotypes, but seemed to extend into
more distal regions of the retina in mutants (Figures 2U and 2V)
compared to controls (Figures 2R and 2S). Although the neuro-
genicmarkerMath5wasnot induced in themutant CMZ, the find-
ings on Brn-3b suggested that this niche might adopt a partial
neurogenic character when LRP2 activity is lost. To further sub-
stantiate changes in Brn-3b expression, we dissected the neural
retina and CMZ from E16.5 eyes for quantitative (q) RT-PCR.
Transcripts of Brn-3b and Lrp2 were prominent in the neural
retina andCMZ, respectively, documenting proper tissue dissec-
tion (Figure S2E). In line with the observations made by immuno-
detection, transcript levels of Brn-3b, but not of Zic2 and Isl2,
were increased in the LRP2-deficient CMZ (Figure S2E).
Our data suggested a distal shift of the boundary between the
central retina and CMZ in LRP2-deficient eyes. A role for LRP2 in
specification of the retinal margin was confirmed by investigating
morphogen pathways in the CMZ by in situ hybridizations (ISH).
At E16.5, CMZ markers Bmp4,Msx1, and Otx1 were expressed
at the correct position in mutant eyes, indicating proper estab-
lishment of the CMZ at the retinal periphery (Figure 3A). How-
ever, the SHH targets Hes1 and Gli1, which were not expressed
in the CMZ of control eyes (Figures 3B, b, f, and j), were ectopi-
cally induced in the Lrp2/ CMZ (Figures 3B, d, h, and l). Also,
Ptch1 levels were increased (Figure 3C). Significantly elevated
transcript levels for Gli1 and Ptch1 in the mutant CMZ, but not
in the neural retina, were confirmed by qPCR (Figure 3D). Tran-
script levels of Shh were not changed in the neural retina or
CMZ of the mutants (Figure 3D), in line with findings obtained
by ISH in Figures 2E and 2F above.
Aberrant induction of the SHH pathway in the mutant CMZ
was confirmed by crossing the Lrp2 null allele with theGli1_LacZ
reporter line (Bai et al., 2002). In E16.5 control eyes, GLI1-depen-
dent lacZ activity was restricted to the neural retina, but absent
from the CMZ (Figures 3E, a and b). In contrast, in Lrp2/
eyes, lacZ activity was ectopically induced in the CMZ (Figures
3E, c and d). Induction of the SHH pathway in the Lrp2/
CMZ coincided with loss of WNT activity in this tissue as shown
by crossing the Lrp2 null allele with the Tcf/Lef_LacZ reporter
strain (Mohamed et al., 2004). As seen in Figure 3E, expression
(Figures 3E, i–j) and activity (Figures 3E, e and f) of lacZ was
seen in the CMZ, but not in the neural retina, of E16.5 control
mice. In contrast, Tcf/Lef-dependent expression (Figures 3E,
k and l) and activity (Figures 3E, g and h) of lacZ was significantly
reduced in the Lrp2/ CMZ. Loss of WNT activity in the E16.5
mutant eye was not due to earlier defects, as components of
the WNT pathway, such asWnt7b and G protein coupled recep-
tor 177, were normally expressed in the mutant eye at E10.5–
11.5 (Figure S3A).
Eye development not only depends on SHH, but also on the
related morphogen indian hedgehog (IHH) produced by the
choroid adjacent to the RPE (Dakubo et al., 2008). Expression
of Ihh in the choroid was unchanged in Lrp2/ mice (Fig-
ure S3B). Also expression of Pitx2, an IHH target in the choroidlopmental Cell 35, 36–48, October 12, 2015 ª2015 Elsevier Inc. 37
Figure 1. LRP2 Deficiency Causes Hereditary Buphthalmos
(A–D) Adult Lrp2267/ mouse and littermate control. Note the exophthalmic eyes (buphthalmos) in the Lrp2267/ animal (C and D).
(E and F) Eye size at 10 weeks of age (E) and postnatal day (P) 10 (F). The scale bar represents 1 mm.
(G and H) (G) Axial length and lens thickness as determined on transverse sections of P10 eyes (exemplified in H, c). The axial length is increased in Lrp2267/
compared to control animals (n = 5 per genotype; **p < 0.01; and Mann-Whitney U test). The values are mean ± SEM (H). The H&E-stained transverse sections of
adult and P10 eyes showing increased globe diameter (a–d), thinning of the retina (e–h), as well as hyperplasia of the non-pigmented epithelium of the CB (arrows;
i–l) in Lrp2267/ animals in both age groups. The lines in (c) indicate the measurement of the axial length and lens thickness as quantified in (G).
(I) Analyses as in (H) for P0.5 eyes. The Lrp2/ eyes show normal diameter (a and b) and retinal thickness (c and d), but hyperplasia of the CB (e and f). The
immunohistological detection of LRP2 in the CB of all age groups is shown in (H, m–p) and (I, g and h). The scale bars represent 50 mm. See also Figure S1.
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Figure 2. Loss of LRP2 Does Not Impact
Stratification of the Retina
(A and B) H&E stained sections of neural retina and
CMZ (brackets) in E16.5 embryos.
(C–J) In situ hybridization on sections of E16.5
mouse eyes indicates expression of Shh (arrow-
heads) andMath5 in the neural retina, but absence
from the CMZ (encircled) of control and Lrp2/
embryos.
(K–P) Immunodetectionof zincfingerprotein2 (Zic2;
red) and insulin-related protein 2 (Isl2; green) in the
neural retina of control and Lrp2/ E16.5 mouse
embryos. The coexpression of both proteins in the
ventrotemporal crescent of the retina is depicted in
(M) and (P) (yellow signal). There is no expression
seen in the CMZ (arrowheads in M and P).
(Q–V) Immunodetection of Brn-3b (red) shows
similar patterns in the neural retina of control (Q)
and Lrp2/ (T) E16.5 mouse embryos. However,
in the mutants, Brn-3b signals extend further into
the distal margin of the retina as shown for the
dorsal (U) and ventral (V) tip. The brackets mark
the distal margin free of Brn-3b signals in control
and LRP2-deficient eyes. The scale bars represent
100 mm. See also Figure S2.was not altered (Figure S3B), suggesting changes in the activity
of SHH (not of IHH) as the cause for induction of the hedgehog
pathway in the LRP2-deficient CMZ.
BOC, CDON, and GAS1 are also expressed in the CMZ, impli-
cating several SHH binding proteins in formation of the retinal
margin. Yet, the expression patterns for Boc, Cdon, and Gas1Developmental Cell 35, 36–4were indistinguishable comparing LRP2-
deficient and control E16.5 eyes by ISH
(Figure S3C) and qPCR (Figure S3D),
excluding defects in expression of these
proteins in the pathology of Lrp2/ eyes.
Expansion of the RPC Pool in the
LRP2-Deficient Retinal Margin
In the rodent retina, SHH acts as a potent
mitogen that promotes RPC proliferation
(Jensen and Wallace, 1997; Levine et al.,
1997; Wang et al., 2002). The absence of
Hh activity from the CMZ contributes to
the quiescence of RPC in this niche in
the mammalian eye (Moshiri and Reh,
2004). In line with this assumption, aber-
rant spread of SHH activity into the CMZ
of the Lrp2/ retina resulted in the expan-
sion of the RPC pool in the retinal margin
as documented by detection of progenitor
cell markers SOX2 and VSX2 by immuno-
histology and qPCR. In wild-types, the
expression domains for both progenitor
cell markers sharply decreased distal to
the boundary between the neural retina
and CMZ (Figure 4A). In mutants, the
signals were prominently induced in the
CMZ (Figure 4A). Elevated levels ofSOX2 and VSX2 in the CMZ (but not in the neural retina) were
confirmed by quantification of immunosignals (Figure 4B) and
by qPCR (Figure 4C).
In addition to increased RPC numbers, the mutant CMZ also
showed enhanced proliferative capacity as verified by the quan-
tification of cells in S phase using in utero labeling with BrdU8, October 12, 2015 ª2015 Elsevier Inc. 39
Figure 3. Ectopic Induction of SHH
Signaling and Loss of WNT Activity in the
LRP2-Deficient CMZ
(A) ISH on sections of E16.5 mouse eyes using
probes for the indicated CMZ markers. The over-
views of the eyes are shown in the left, while
enlarged views of the CMZ are given in the right.
The expression domains for Bmp4 (a–d), Msx1
(e–h), and Otx1 (i–l) are identical in control and
Lrp2/ E16.5 embryos.
(B) ISH on E16.5 mouse eyes using probes for
targets of SHH signaling. The Lrp2/mouse eyes
exhibit an aberrant induction ofHes1 (as shown for
two individuals; arrowheads in d and h) and ofGli1
(arrowheads in l) as compared to controls (b, f,
and i). The ectopic induction was seen in three out
of five (Hes1) and in four out of five (Gli1) embryos
analyzed.
(C) ISH indicates elevated levels of Ptch1 in the
CMZ (encircled) of mutant compared to control
E16.5 eyes.
(D) qRT-PCR forGli1,Ptch1, andShh transcripts in
the CMZ and neural retina of mice. The levels of
transcripts are given relative to the control retina
(set to 1). The levels for Ptch1 and Gli1 are signif-
icantly increased in the CMZ, but not in the neural
retina of mutant embryos (n = 7–12 animals per
group; Student’s t test). The data are depicted as
fold changes ± error.
(E) Staining for lacZ activity (arrowheads) on sec-
tions of E16.5 mouse eyes from Gli1_LacZ (a–d)
and Tcf/Lef_LacZ (e–h) reporter lines. The mice
express (control) or lack LRP2 (Lrp2/). In the
LRP2-deficient CMZ, the activity of the GLI1-
dependent LacZ reporter is aberrantly induced (d)
as compared to the control tissue (b) (seen in nine
out of 16 embryos). The activity of the Tcf/Lef-dependent lacZ reporter gene is diminished in the mutant (h) compared to the control (f) CMZ (in seven out of nine
embryos). The reduction of Tcf/Lef-dependent lacZ expression in Lrp2/ (l) compared to the control CMZ (j) was confirmed by ISH for lacZ (i–l). The arrowheads
highlight the CMZ. The scale bars represent 100 mm. See also Figure S3.(Figures 4D and 4E), immunodetection of mitotic marker phos-
phohistone H3 (PH3) (Figures 4D and 4F), or cell-cycle marker
Ki67 (Figures 4D and 4G). In all assays, the numbers of prolifer-
ating cells were 3-fold higher in the LRP2-deficient compared to
the control CMZ. The number of mitotic cells in the neural retina
was unchanged (Figures S4A and S4B). Hyperproliferation of the
mutant CMZ continued into the postnatal period as shown by
BrdU labeling in P0.5 mice (Figures S4C and S4D). BrdU+ cells
costained for SOX2, suggesting proliferation of RPCs as a cause
of the enhanced mitotic activity in the Lrp2/CMZ (Figure S4E).
LRP2 Deficiency Enhances SHH-Dependent Cell
Proliferation in the CMZ
We applied a retinal explant model to dissect the pathways un-
derlying the enhanced mitogenic potential of the LRP2-deficient
CMZ at E16.5 (Figures S5A and S5B) (Liu et al., 2007). Retinal ex-
plants were cultured for up to 48 hr, retaining their identity as
judged by expression of LRP2 and Msx1 in the CMZ, and of
Brn-3b in the neural retina (Figure S5C).
Initially, we investigated whether the LRP2-deficient CMZ in
retinal explants showed higher proliferative capacity as seen
in vivo. Applying BrdU labeling in explants cultured for 24 hr, we
confirmed an increase in BrdU+ cells in the mutant compared to
the control CMZ (Figures 5A and 5B). Enhanced proliferation in40 Developmental Cell 35, 36–48, October 12, 2015 ª2015 Elsevier Ithe mutant CMZ was dependent on SMO activity, as application
of the inhibitor KAAD-cyclopamine decreased the number of
BrdU+ cells in mutants to wild-type levels (Figure 5B). Impaired
proliferative response in the control CMZ was not due to a lack
of SHH pathway components, as application of Smoothened
agonist (SAG) stimulated proliferation to similar levels in control
and mutant tissues (Figure 5C). Application of SAG also caused
loss of WNT signals in the CMZ of control explants from Tcf/Lef_
LacZmice (Figure 5D), arguing that the reduction of WNT activity
in the Lrp2/ CMZ is a consequence of ectopic SHH activation.
To exclude loss of WNT activity as the primary cause of hyper-
proliferation in the Lrp2mutant CMZ, we treated wild-type retinal
explants from the Tcf/Lef_LacZ line with the WNT inhibitor JW55
(Waaler et al., 2012) (Figure 5E). Application of JW55 caused loss
of WNT activity in the CMZ (as shown by lacZ staining; Fig-
ure 5E, c), but failed to induce cell proliferation above levels in
buffer-treated explants (shownbyBrdU incorporation; Figure 5E,
d). However, induction of cell proliferation was achieved in
JW55-treated explants by coapplication of SAG (Figure 5E, f).
LRP2 Mediates Clearance of SHH to Antagonize
Morphogen Activity
Having established an explant model that faithfully recapitulates
features of the LRP2-deficient CMZ in vivo, we tested thenc.
Figure 4. Aberrant Expansion of the
Retinal Progenitor Cell Pool in the LRP2-
Deficient CMZ
(A) Immunohistological detection of RPC markers
SOX2 and VSX2 documenting upregulation in the
mutant compared to the control E16.5 CMZ
(circled by white lines).
(B) The increase in SOX2 signal in the mutant as
compared to the control CMZ (as exemplified in A)
was quantified as relative fluorescence intensity
(n = 5–7 eyes per genotype).
(C) Increased transcript levels for Vsx2 in the CMZ,
but not in the neural retina of Lrp2/ compared to
control E16.5 eyes. The transcript levels are given
relative to the control retina (set to 1) (n = 7–8 an-
imals per group; Student’s t test). The data are
depicted as fold changes ± error.
(D) In utero labeling with BrdU or immunodetection
of PH3 or Ki67 documented an increase in the
number of mitotic cells in the LRP2-deficient
compared to the control E16.5 CMZ region (circled
by white lines).
(E–G) Quantification of cells positive for BrdU (E),
PH3 (F), and Ki67 (G) in the LRP2-deficient
compared to the control CMZ (as exemplified in D).
The number of BrdU+ cells was quantified as
relative fluorescence intensity (n = 7–12 eyes per
genotype). The numbers for PH3+ and Ki67+ cells
are given as average cell count per CMZ section
(n = 5–10 eyes per genotype) (*p < 0.05; **p < 0.01;
and Mann Whitney U test). The values are mean ±
SEM. The scale bars represent 50 mm. See also
Figure S4.expression of SHH pathway components in this tissue in the
presence and absence of LRP2. Primary cilia were abundantly
present in the neural retina and, to a lesser extent, in the CMZ
as shown by staining for the ciliary marker Arl13b (Figure 6A).
In the control CMZ, LRP2 localized to the base of the primary
cilium (Figure 6A, inset in d). No difference in the number of
Arl13b+ cilia in the CMZ was seen comparing genotypes (Fig-
ure 6C). However, a striking difference was noted when cilia
were costained for GLI2 and SMO as an indicator of pathway
activation (Figure 6B). In controls, SMO signals were observed
in GLI2+ primary cilia in the neural retina (Figure 6B, a), butDevelopmental Cell 35, 36–4were absent from cilia in the CMZ (Fig-
ure 6B, b). In contrast, robust ciliary stain-
ing for SMO was seen in the mutant CMZ
(Figure 6B, d). An approximate 3-fold
increase in SMO+ cilia in the CMZ was
confirmed by quantification (Figure 6C),
documenting aberrant activation of the
SHH pathway in the LRP2-deficient
retinal margin. The extent of SHH
pathway activation matched well with a
similar 3-fold increase in mitogenic stimuli
received by the Lrp2-deficient CMZ
(as shown by quantification of BrdU+,
Ki67+, and PH3+ cells; Figures 4D–4G).
As well as in retinal explants, this increase
in SMO+ primary cilia in the mutant CMZwas also confirmed on histological sections of the E16.5 mouse
eye (Figures S6A and S6B). Aberrant pathway activation in the
CMZ coincided with a clear change in the distribution of endog-
enous SHH ligand in the mutant eye as shown by western blot
analysis of dissected tissues. Although the levels of SHH protein
were slightly lower in the neural retina, they were almost 2-fold
increased in the CMZ of Lrp2/ compared to control eyes
(Figure 6D).
To explore the reason for accumulation of endogenous SHH
in the mutant CMZ, we investigated the fate of the morphogen
in the retina. When we incubated control explants with a8, October 12, 2015 ª2015 Elsevier Inc. 41
Figure 5. LRP2 Deficiency Enhances SHH-
Dependent Cell Proliferation in the CMZ
(A) Immunodetection of BrdU+ cells in the CMZ of
E16.5 control and Lrp2/ retinal explants cultured
for 24 hr. The CMZ is encircled by a white line. The
BrdU+ cells in the neural retina (arrowhead) and
lens (asterisks) are indicated.
(B and C) Quantification of BrdU+ cells in the CMZ
of control and Lrp2/ retinal explants after 24 hr
incubation. The explants in (B) were incubated in
3 mMKAAD-cyclopamine or in solvent DMSO only.
The explants in (C) were incubated in 800 nM SAG
or buffer (n = 5–12 per genotype) (not significant:
n.s.; **p < 0.01; ***p < 0.001; and two-way ANOVA
followed by Bonferroni post test). The values are
mean ± SD.
(D) Loss of lacZ activity in the CMZ (arrowheads) of
control explants of the Tcf/Lef-lacZ line treated for
36–48 hr with 800 nM SAG as compared to buffer-
treated tissues (seen in three out of six explants
analyzed).
(E) Wild-type retinal explants of the Tcf/Lef-lacZ
line were treated for 24 hr with buffer (a and b),
5 mM JW55 (c and d), or 5 mM JW55 and 800 nM
SAG (e and f). The suppression of WNT signaling in
JW55-treated explants (reduced lacZ signal in c)
does not increase cell proliferation in the CMZ
(encircled) above levels in the buffer control as
shown by BrdU staining (b and d; seen in eight out
of eight explants). However, induction of prolifer-
ation in the CMZ is seen in JW55-treated explants
that received SAG (f; seen in three out of three
explants analyzed) (lens: le). The scale bar repre-
sents 75 mm. See also Figure S5.recombinant fusion protein of SHH-N and GST, intracellular
accumulation of the ligand was detected in the CMZ, but not in
the neural retina (that does not express LRP2) (Figures 6E, a
and b and e and f). Uptake was mediated by LRP2 as no uptake
of GST-SHH-N was seen in the LRP2-deficient CMZ (Figures
6E, c and d). No internalization was observed for GST only (Fig-
ure S6C).When costained for endocytic markers, LRP2 localized
to clathrin-coated pits (AP2), early endosomes (Rab4), and recy-
cling endosomes (Rab11), but not to lysosomes (Lamp1) in the
control CMZ (Figure 6F, upper). This pattern is consistent with
the recycling fate of an endocytic receptor. In contrast, internal-
ized GST-SHH-N localized to early endosomes (Rab4) and
lysosomes (Lamp1 and cathepsin B), but not to recycling endo-
somes (Rab11) (Figure 6F, lower). This subcellular distribution of
GST-SHH-Nwas surprising because in the RDVM, LRP2 delivers
SHH to the Rab11+ recycling compartment, but not to lyso-
somes (Christ et al., 2012).
To substantiate lysosomal targeting of SHH in the CMZ, we
performed uptake assays in control explants. First, we tested
intracellular localization of GST-SHH-N in explants treated with
chloroquine, an inhibitor of lysosomal degradation that causes
swelling of the lysosomes. Application of chloroquine resulted
in accumulation of large vesicles in the CMZ that costained for
LRP2 and GST-SHH-N. This pattern was distinctly different
from the apical vesicular signals seen for LRP2 and GST-SHH-
N in untreated tissue (Figure S6D). Second, we coincubated
control explants with GST-SHH-N and lactoglobulin, a ligand
delivered to lysosomes. Both proteins colocalized in intracellular42 Developmental Cell 35, 36–48, October 12, 2015 ª2015 Elsevier Ivesicles in the control CMZ (Figure S6E). To confirm lysosomal
sorting, we purified lysosomes from control explants incubated
with GST-SHH-N for 4 hr. As shown in Figure S6F, GST-SHH-
N present in the postnuclear supernatant efficiently copurified
with Lamp1.
Conceivably, LRP2-mediated lysosomal catabolism of SHH
antagonizes morphogen activity in target cells. This hypothesis
was tested by luciferase reporter assay. To do so, conditioned
media from HEK293 cells secreting SHH-Np were incubated at
37C for 14–16 hr in empty 24-well plates or in 24-well plates
containing a monolayer of rat choriocarcinoma (BN16) cells.
BN16 cells express LRP2 and are commonly used to test the en-
docytic activity of this receptor. Western blot analysis confirmed
depletion of SHH-Np from the supernatant of BN16 cells
compared to the empty well control (Figure S6G; SHH-Np).
Clearance of SHH-Np from the supernatant was also seen
when non-immune serumwas added to the conditionedmedium
(SHH-Np + non-IgG), but was blocked when anti-LRP2 anti-
serum was applied (SHH-Np + a-LRP2). Finally, clearance was
inhibited by application of chloroquine, indicating lysosomal
involvement in SHH-Np depletion (Figure S6H). When the re-
maining SHH activity in themedia was scored by GLI-dependent
firefly luciferase reporter assay in Shh Light II cells (Taipale et al.,
2000), the relative firefly luciferase activity was reduced in me-
dium incubated with BN16 cells compared to empty well incuba-
tions. This effect was seen for medium containing SHH-Np
alone or SHH-Np with non-immune IgG (Figure S6I). However,
no difference in SHH activity in Shh Light II cells comparingnc.
Figure 6. LRP2 Mediates Lysosomal Catabolism of SHH to Antagonize Morphogen Activity
(A) Immunodetection of Arl13b in CMZ and neural retina of Lrp2/ and control E16.5 retinal explants. The Arl13+ primary cilia (red) are seen in the neural retina
and to a lesser extent in the CMZ (indicted by white lines) in both genotypes as shown in overview (a and b) and in higher magnification micrographs (c–f). The
asterisks in (a) and (b) mark primary cilia in the lens. The insets show localization of LRP2 (green) at the ciliary base in control (d), but not Lrp2/ (f) CMZ tissue.
(B) Immunodetection of SMO (red) and ciliary marker GLI2 (green) identifies cilia positive for SMO (arrowheads) in the mutant (d), but not in the control (b) CMZ. In
the neural retina, SMO+ cilia are seen in both genotypes (a and c).
(C) Quantification of primary cilia positive for Arl13b and SMO in control and Lrp2/ CMZ explants (as exemplified in A and B). The cilia per histological section
was determined in n = 11–13 animals. (not significant: n.s.; ***p < 0.001; and Mann-Whitney U test). The values are mean ± SD.
(D) Levels of endogenous SHH are slightly decreased in the neural retina, but increased in the CMZ of Lrp2/ compared to control eyes as documented by
western blotting of dissected tissues (exemplified in the inset) and by densitometric scanning of replicate blots (n = 4–7 pools per genotype; eight eyes per pool for
the CMZ, two to five eyes per pool for the neural retina). The SHH levels in the mutant tissues were corrected for the tubulin loading control and are given as %
signal of the respective control pool (set to 100%; column statistics and one sample t test).
(E) Immunodetection of LRP2 (green) and SHH (red) in control and Lrp2/ retinal explants treated with GST-SHH-N. The overviews (a, c, e, and g) as well as
higher magnifications (b, d, f, and h) of the neural retina and CMZ are shown. In controls, robust uptake of GST-SHH-N is seen in the CMZ (a and b), but not in the
neural retina (e and f). No uptake of GST-SHH-N into the CMZ (c and d) or the neural retina (g and h) is seen in the Lrp2/ explants.
(F) Control explants were incubated with 5 mg/ml GST-SHH-N and subsequently stained for LRP2 (upper) or GST-SHH (lower) and the indicated markers. The
LRP2 (green) localizes with markers (red) of clathrin-coated pits (AP2), early (Rab4), and recycling (Rab11) endosomes, but not lysosomes (Lamp1). In contrast,
internalized GST-SHH-N (red) colocalizes with markers (green) of early endosomes (Rab4) and lysosomes (Lamp1 or cathepsin B [CatB]), but not with recycling
endosomal marker Rab11. The scale bars represent 5 mm (A, c; B, a) and 25 mm. See also Figure S6.BN16- and empty-well incubations was seen in the presence of
anti-LRP2 antiserum (Figure S6I).
LRP2 Increases the Threshold for SHH Signals to
Suppress Mitogenic Stimuli in the CMZ
Data in Figures 6 and S6 provided cumulative evidence that
LRP2 facilitates clearance of SHH by cells in the CMZ, thereby
antagonizing morphogen activity in the retinal margin. To put
this concept to the test, we compared the response of control
and LRP2-deficient CMZ explants to SHH-Np (Figure S7A).
Incorporation of BrdU served as a measure of the mitogenic po-
tential of SHH in these tissues (Figure S7B). To do so, we used
48 hr incubations of retinal explants contrary to the analyses of
endogenous SHH activity in experiments after 24 hr (FiguresDeve5A–5C). In explants treated with blank medium for 48 hr, the
proliferative capacity was low, reaching comparable levels in
control and mutant CMZ. This residual proliferation was not
inhibited by KAAD-cyclopamine (Figure 7C; condition 0 mg/ml
SHH-Np). This finding is in line with earlier observations that
loss of retinal ganglion cells depletes the source for SHH from
retinal explants incubated for an extended period of time
(Wang et al., 2002). Still after 48 hr, explants of both genotypes
responded to exogenous SHH-Np from conditioned media
by induction of proliferation in the CMZ as shown by BrdU incor-
poration. Proliferation was blocked by KAAD-cyclopamine (Fig-
ures 7A and 7B). Foremost, these data confirmed the ability of
both genotypes to activate the ligand-dependent SHH pathway
in the CMZ.lopmental Cell 35, 36–48, October 12, 2015 ª2015 Elsevier Inc. 43
Figure 7. LRP2 Increases the Threshold for SHH Signaling to Suppress Mitogenic Stimuli in the Peripheral Retina
(A and B) Immunodetection of BrdU+ cells (red) in the CMZ of control and Lrp2/ retinal explants cultured for 48 hr in the presence of 0.05 mg/ml (A) or 0.2 mg/ml
(B) SHH-Np. Where indicated, the medium also included 1 mM KAAD-cyclopamine or the solvent DMSO. The CMZ is encircled by a white line. The scale bar
represents 75 mm.
(C) Quantification of the number of BrdU+ cells per CMZ section (as in A and B) for retinal explants incubated for 48 hr in the absence (0 mg/ml) or in the presence of
the indicated concentrations of SHH-Np (as exemplified in A and B). The SHH-Np-induced stimulation of proliferation is blocked by 1 mM KAAD-cyclopamine in
both genotypes (n = 3–14 per genotype) (*p < 0.05 and two-way ANOVA followed by Bonferroni post test).
(D) Dose-response curve of the number of BrdU+ cells in control and Lrp2/ CMZ explants treated with the indicated concentrations of SHH-Np for 48 hr. The
curves were fitted assuming a sigmoidal dose-response (variable slope). The comparison of fits: F (5.64; 1.54). The concentration of SHH-Np required to elicit half
maximal response (EC50; dotted lines) is given (n = 5–9 per condition and genotype; p = 0.018). The values are mean ± SEM.
(E) Immunodetection of PTCH1 and GLI2 in the CMZ of retinal explants treated with buffer or SAG. In control and Lrp2/ tissues, PTCH1 is present in apical
vesicles and at the cells surface (a and b) and enriched in GLI2+ cilia upon SAG stimulation (arrowheads in c and d). No colocalization is seen for LRP2 (green) and
PTCH1 (red) in buffer (e) or SAG treated (g) CMZ explants. For comparison, the inset in (e) depicts colocalization of LRP2 and PTCH1 in the E10.5 RDVM. The scale
bar represents 5 mm.
(F) Explants of E16.5 CMZ or E8.5 RDVM were incubated with GST or GST-SHH-N for 2 hr and immunostained for PTCH1 (red) and ligand (green). The efficient
uptake of GST-SHH-N is seen in control CMZ (c) and RDVM (g), but not in LRP2-deficient tissues (d and h). No uptake of GST is seen in any condition (a, b, e,
and f). The LRP2-mediated uptake of GST-SHH-N results in cointernalization of PTCH1 in the RDVM (yellow signals in g), but fails to cointernalize PTCH1 in the
CMZ (green signals in c). The scale bar represents 10 mm (a) or 50 mm (b).
(G)Modulation of SHH signaling by LRP2. Under basal conditions (a), binding of SHH to PTCH1 results in internalization of PTCH1 and in pathway activation. In the
RDVM (b), LRP2 promotes signaling by interacting with PTCH1 to facilitate high-affinity binding and internalization of PTCH1/SHH complexes. The SHH is
recycled via Rab11+ sorting pathways. In the CMZ (c), LRP2 fails to interact with PTCH1 and directs lysosomal catabolism of the internalized morphogen (c). See
also Figure S7.An intriguing difference between control and Lrp2/ explants
was noted when their response to defined concentrations of
exogenous SHH-Np was scored. At 0.05 mg/ml of SHH-Np,
both genotypes reacted with an increase in BrdU+ cells in the
CMZ as compared to blank medium or KAAD-cyclopamine44 Developmental Cell 35, 36–48, October 12, 2015 ª2015 Elsevier Itreated tissues, but this increase was significantly higher in
Lrp2/ as compared to control explants (Figure 7C). This
difference was not seen using 4-fold higher concentrations of
SHH-Np, when both genotypes responded equally (Figure 7C;
0.2 mg/ml). To provide a quantitative description of the sensitivitync.
to SHH, we scored the response of control and mutant explants
to a range of SHH concentrations (determined by semiquantita-
tive western blotting; Figure S7A). When the dose-response
curves were determined, the effective concentration of SHH-
Np to elicit a half-maximal proliferative response (EC50) was
0.06 mg/ml in controls, but 0.02 mg/ml in the Lrp2 null CMZ (Fig-
ure 7D; p = 0.018). Thus, LRP2 activity in the control CMZ
increased the threshold required to elicit a mitogenic response.
In the RDVM, LRP2-mediated internalization of SHH results in
concurrent internalization of PTCH1, a prerequisite for pathway
activation (Christ et al., 2012). Accordingly, we explored the
cellular fate of PTCH1 in the CMZ in the presence or absence
of SHH ligand. The specificity of the PTCH1 antiserum was
confirmed on E16.5 eyes from mice with conditional inactivation
of Ptch1 in the retina (Figure S7C). In the CMZ, PTCH1 was pre-
sent at the apical cell surface and in intracellular vesicles (Figures
7E, a and b). Treatment of explants with SAG results in enrich-
ment of PTCH1 in GLI2+ cilia, an activity of PTCH1 documented
in other cell types before (Rohatgi et al., 2007) (Figures 7E, c
and d). No discernable difference in PTCH1 localization was
observed comparing control and LRP2-deficient CMZ. Surpris-
ingly, no colocalization of PTCH1 and LRP2 was noted in the
control CMZ treated with buffer or SAG (Figures 7E, e and g).
Such colocalization of LRP2 and PTCH1 was clearly noticeable
in the RDVM (Figure 7E, inset in e) (Christ et al., 2012). In line
with the lack of colocalization, LRP2-dependent internalization
of GST-SHH-N in the control CMZ failed to efficiently cointernal-
ize PTCH1 with the ligand (Figure 7F, c), whereas cointernaliza-
tion of PTCH1 and GST-SHH-N was obvious in the RDVM
(Figure 7F, g). These findings suggested distinct cellular mecha-
nisms in the CMZ and RDVM that distinguish the ability of LRP2
to functionally interact with PTCH1 and to direct SHH to lyso-
somal versus recycling fates.
In conclusion, our data substantiated a role for LRP2 in control
of SHH signaling that extends forebrain formation. In the retina,
the endocytic activity of this receptor limits the distal spread of
the SHH activity domain and protects RPC in theCMZ frommito-
genic stimuli, a process that otherwise results in hyperplasia of
the CB and in hereditary buphthalmos.
DISCUSSION
LRP2 Deficiency Causes Ectopic Induction of SHH
Activity in the Retinal Margin
SHH is essential for several steps of mammalian eye develop-
ment. Initially, SHH secreted from the prechordal plate induces
formation of the optic primordia from a single eye field (Zhao
et al., 2012). At subsequent stages of eye development, SHH
produced locally by retinal ganglion cells assumes an important
function in patterning of the neural retina by acting on RPC
(Wang et al., 2005). In LRP2-deficient mice, formation of the op-
tic pits proceeds normally as judged by the presence of two
laterally placed eyes (Figures 1C and 1D). Proper establishment
of bilateral eye structures is likely due to the fact that LRP2 defi-
ciency does not impact production of SHH in the prechordal
plate (Christ et al., 2012).
While LRP2 deficiency does not impair SHH-dependent
patterning of the optic pits, it affects local SHH activity during
later stages of retina development. The source and the activityDevedomain of SHH in the neural retina are not altered by LRP2 defi-
ciency, as Shh and markers of postmitotic retinal cell types are
properly expressed (Figure 2). Also, the postnatal retina shows
correct stratification (Figures 1H and S1E). However, LRP2 defi-
ciency causes a shift of the peripheral boundary of the SHH
activity domain into the distal retinal margin. This fact was docu-
mented by increased signals for retinal ganglion cell marker
Brn-3b (Figures 2U, 2V, and S2E), as well as for progenitor cell
markers SOX2 and VSX2 (Figures 4A–4C) in the mutant CMZ.
Enhanced SHH activity is the likely cause of this phenotype, as
increased levels of downstream targets Gli1, Hes1, and Ptch1
(Figures 3B–3D), and of Gli1-lacZ activity (Figure 3E) are seen
in this tissue. As a consequence of increased SHH signal, the
RPC pool in the mutant CMZ is expanded and the proliferative
capacity of the retinal margin enhanced (Figure 4). Expression
levels for Zic2 and Isl2, marking ipsilateral and contralateral pro-
jecting ganglion cells, respectively, are not significantly altered in
the Lrp2/ eye (Figure S2E). A decrease in ipsilateral projections
had been documented in mice lacking Boc before (Sa´nchez-
Arrones et al., 2013). Thus, LRP2 activity mainly impacts the
size of the progenitor cell pool in the CMZ, while differentiation
to more specialized retinal cell types may require additional reg-
ulatory signals. LRP2-dependent expansion of the RPC pool
may occur through SHH-induced proliferation of multipotent
progenitor cells as suggested by double labeling of cells for
BrdU and SOX2 (Figure S4E). Alternatively, CMZ cell types
may adopt a partial RPC fate in response to SHH.
A function for LRP2 in the retinal margin is supported by
its predominant expression in the CMZ (Figure S2). The SHH
pathway is the target of receptor (dys)function, as other
morphogen pathways are not altered (e.g., Ihh and Bmp4) (Fig-
ures 3A and S3B) or decreased secondarily as shown by down-
regulation of WNT activity by SAG (Figure 5D). Enhanced RPC
proliferation as a consequence of increased Hh signaling is
also seen inmice heterozygous for the Ptch1 gene defect (Mosh-
iri and Reh, 2004) or in animals lacking Sufu, an inhibitor of the
SHH pathway (Cwinn et al., 2011). In contrast, a WNT signaling
defect in mice lacking b-catenin in the retina causes a decrease,
rather than an increase, in the progenitor cell pool (Liu et al.,
2007). Also, blockade ofWNT activity by JW55 in this study failed
to induce cell proliferation in the CMZ (Figure 5E). Consistent
with the main role of SHH to stimulate proliferation (Sakagami
et al., 2009; Wang et al., 2005), ectopic SHH activity in the
Lrp2/ CMZ enhances proliferative capacity, impairing the
quiescent character of RPCs in the CMZ (Figure 4).
LRP2 Defines the Boundary of the SHH Activity Domain
in the Retina
All components of the SHH signaling machinery, including pri-
mary cilia, SMO, PTCH1, and GLI2 are present in the wild-type
CMZ as documented by ISH, immunohistology, and qPCR.
Also, the wild-type CMZ avidly reacts to SHH-Np (Figures 7A–
7D and S7B) and SAG (Figure 5C) with proliferative responses
equaling that of Lrp2/ tissue. The fact that SMO is excluded
from primary cilia in the control CMZ indicates lack of sufficient
SHH signal in the retinal margin of thewild-type eye. This hypoth-
esis was confirmed by quantitative description of the response
of the CMZ to exogenous SHH-Np. In control tissue, the EC50
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unchanged as compared to the Lrp2/CMZ (Figure 7D). This ki-
netic is representative of a competitive inhibitor (LRP2) present in
the control, but absent from the mutant condition.
Because LRP2 delivers SHH to lysosomes in CMZ cells (Fig-
ures 6F and S6C–S6E) and antagonizes SHH signaling in trans
in luciferase reporter assays (Figure S6I), we propose a model
whereby the endocytic activity of this receptor provides a
morphogen sink that depletes the ligand from the peripheral
margin. Most importantly, this model is supported by the accu-
mulation of endogenous SHH protein in the mutant CMZ (Fig-
ure 6D). Accumulation of SHH in the CMZ is not caused by
increased expression, as levels of SHH in the neural retina or
levels of Shh transcripts in the neural retina or CMZ are not
increased in the Lrp2/ compared to control eyes. In non-
mammalian systems, the ability of Hh binding proteins to contain
the spread and activity of this mophogen has been shown in the
wing disc (Bilioni et al., 2013; Yan et al., 2010) and ovaries (Hart-
man et al., 2010) of the fruit fly or in the optic vesicle of zebrafish
and chick embryos (Cardozo et al., 2014).
Loss of Quiescence Results in Hyperproliferation of the
Retinal Margin and in Eye Pathology
Aberrant proliferation of the CMZ in Lrp2 mutant mice proceeds
into the postnatal period (Figures S4C and S4D) and coincides
with hyperplasia of the CB in newborn mice (Figure 1I). The in-
crease in postnatal eye size in Lrp2/ animals is most likely
caused by hyperproliferation of the embryonic CMZ, as mice
with conditional Lrp2 inactivation in the adult lack eye pathology
(Storm et al., 2014). High myopia (nearsightedness), a defect
caused by increased axial length, is also a consistent feature
seen in individuals with Donnai-Barrow syndrome (Pober et al.,
2009). While intraocular pressure cannot be determined accu-
rately in neonatal mice, glaucomatous changes, such as thinning
of the retina and loss of retinal ganglion cells, argue for an
increased pressure as the cause of the buphthalmos in Lrp2
null animals. This conclusion is supported by the identification
of mutations in lrp2 in zebrafish in ENU screens for glaucoma
genes (Veth et al., 2011). Possibly, quiescence of themammalian
CMZ assures integrity of the CB that produces the vitreous and
causes glaucoma when dysfunctional.
Context-Dependent Function of LRP2 in the SHH
Pathway
The ability of LRP2 to antagonize SHH signaling in the CMZ is
surprising, considering its role as an activator of this pathway
in the RDVM (Christ et al., 2012). What may be the molecular
concept that determines context-dependent stimulation or
repression of the SHH pathway by this receptor? Based on anal-
ysis of endogenous SHH pathway components, two concurrent
mechanisms seem plausible, namely, the cell-type specific con-
trol of trafficking of SHH and of PTCH1 by LRP2 (Figure 7G). In
the RDVM, LRP2 closely colocalizes with PTCH1 on the apical
cell surface. Binding of SHH to LRP2 results in efficient internal-
ization of ligand and PTCH1, and in subsequent pathway acti-
vation. SHH internalized by LRP2 is delivered to recycling
endosomes, possibly destined for re-secretion to increase local
morphogen concentration in the target field (Christ et al., 2012).
In the CMZ, SHH internalized by LRP2 awaits a different fate as it
is directed to lysosomes, depleting the ligand from the retinal46 Developmental Cell 35, 36–48, October 12, 2015 ª2015 Elsevier Imargin. Also, LRP2 fails to induce cointernalization of PTCH1
(Figure 7F), preventing recruitment of SMO into cilia (Figure 6B).
A role for LRP2 as SHH clearance receptor is supported by the
accumulation of endogenous SHH in the mutant CMZ (Fig-
ure 6D). Obviously, binding of SHH to PTCH1 in the mutant
CMZ results in cellular uptake of morphogen and receptor as
judged from ectopic pathway activation in this tissue. However,
the low levels and the relatively poor clearance capacity of
PTCH1 as compared to the highly efficient endocytic receptor
LRP2 likely precludes intracellular accumulation of endogenous
SHH or exogenously added GST-SHH-N in the mutant CMZ to
levels detectable by immunohistology. Also, much of the SHH
ligand building up in the mutant CMZ may be dispersed in the
intercellular space due to lack of a clearance pathway, further
impeding immunodetection.
The capability of LRP2 to act in a context-dependent manner
is shown by its association with distinct cytosolic adaptors that
determine routing of the receptor through cell type specific sort-
ing pathways (Shah et al., 2013). Concerning control of LRP2 and
PTCH1 interaction, a similar mechanism is operable in the WNT
pathway with transmembrane proteins Kremen 1 and 2 blocking
the ability of LRP5/6 to functionally interact with the WNT recep-
tor frizzled (Mao et al., 2002). Further identification of factors that
govern the cell-type specific interaction of LRP2 with SHH and
PTCH1 will shed light on an important molecular concept
whereby this SHH binding protein assumes functions as acti-
vator or inhibitor to fine-tune the target response to SHH.
EXPERIMENTAL PROCEDURES
Mouse Models
Mice carrying Lrp2 null alleles due to targeted (Spoelgen et al., 2005) or ENU-
induced (Zarbalis et al., 2004) gene disruption have been described before.
Where applicable, these lines were crossed with the Gli1_LacZ (JAX; Stock
008211) or the Tcf/Lef_LacZ reporter lines (Mohamed et al., 2004). Experi-
ments involving animals were performed according to institutional guidelines
following approval by local authorities (X9017/12).
Retinal Explant Cultures
Retinal explants were isolated from E16.5 mouse eyes as published (Liu et al.,
2007). The explants were cultured for 24–48 hr at 37C, with 5% CO2 and
95% humidity. Where indicated, the culture medium (Wang et al., 2005) was
supplemented with 1–5 mM KAAD-cyclopamine (Calbiochem), 800 nM SAG
(Alexis Biochemicals), 5 mM tankyrase inhibitor JW55 (Calbiochem), or 0.05–
0.20 mg/ml SHH-Np in conditionedmedium fromHEK293 cells stably secreting
SHH-Np (SHHN-293 cells; provided byM. Kato, Stanford School of Medicine).
For ligand uptake, retinal explants were incubated for 2 hr with 5 mg/ml GST-
SHH-N (produced in BL21 bacteria using vector pSh1-2tk) or with 10 mg/ml
lactoglobulin (labeled with Alexa-488 using the Protein Labeling Kit; Life Tech-
nologies). Thereafter, explants were washed and fixed in 4% paraformalde-
hyde (PFA) in PBS for 20 min at room temperature and processed for routine
cryo-sectioning.
BrdU Labeling In Utero and in Explants
For BrdU incorporation experiments in retinal explants, the tissue was pulsed
with 10 mM BrdU (Sigma) for 1 hr. To label proliferating cells in the CMZ of
E16.5 embryos, BrdU was injected intraperitoneally into pregnant females at
50 mg/kg body mass and the animals sacrificed 1 hr later. For quantification
of BrdU+ cells, cryo-sections of eyes or explants were subjected to standard
immunohistology using rat anti-BrdU antibody (1:100; AbD Serotec), followed
by biotin-streptavidin amplification procedure. The number of BrdU+ cells in
the CMZ of retinal explants was counted on two sections through the medial
plane of the lens per retinal explant for a total of 5–12 animals per genotypenc.
and condition. In embryonic eyes, the CMZ was defined as the region of inter-
est and immunofluorescence intensities quantified using LAS AF software.
Signal intensities were determined on 3–4 sections per eye for a total of
5–12 animals per genotype and condition.
Statistical Analysis
Statistical significance was calculated using GraphPad Prism 5/6 software.
Results comparing two groups were analyzed either by Student’s t test (Fig-
ures 3D and 4C) or by Mann-Whitney U test (Figures 1G, 4B, 4E–4G, 6C,
S1B, S2E, S3D, S4A, S4B, S4D, and S6I). Results in which more than two
groups and different treatments were compared to each other were analyzed
by two-way ANOVA followed by Bonferroni post test (Figures 5B, 5C, and 7C).
Results shown in Figure 6D were analyzed using one sample t test. Data in
Figure 7D were analyzed using a sigmoidal dose-response (variable slope)
equation. Values are indicated in the figure legends.
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